Literature DB >> 1320549

Pernicious anaemia as a risk factor for osteoporosis.

R Eastell1, N E Vieira, A L Yergey, H W Wahner, M N Silverstein, R Kumar, B L Riggs.   

Abstract

1. If gastric acid is necessary for the absorption of dietary calcium, the total absence of gastric acid secretion that occurs in pernicious anaemia could result in bone loss. To investigate this, we measured calcium absorption and bone density in 21 postmenopausal women (ages 51-76 years) with pernicious anaemia and in 24 normal postmenopausal women (ages 51-79 years). 2. Relative to the normal women, in the women with pernicious anaemia the bone mineral density of the lumbar spine was decreased by 16% (P less than 0.001). 3. After adjustment for age and body weight, lumbar spine bone mineral density correlated with the serum concentration of group 1 pepsinogens (a group of proteins produced by the gastric fundus) (r = 0.61, P less than 0.01). 4. Despite achlorhydria, the women with pernicious anaemia had normal true fractional calcium absorption and normal serum levels of parathyroid hormone and 1,25-dihydroxyvitamin D. 5. We conclude that gastric acid is not required for the absorption of dietary calcium. Thus, the loss of cancellous bone must be caused by some mechanism yet to be identified.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320549     DOI: 10.1042/cs0820681

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  14 in total

Review 1.  Nutrition, bone, and aging: an integrative physiology approach.

Authors:  Rifka C Schulman; Aaron J Weiss; Jeffrey I Mechanick
Journal:  Curr Osteoporos Rep       Date:  2011-12       Impact factor: 5.096

Review 2.  Safety of the long-term use of proton pump inhibitors.

Authors:  Alan B R Thomson; Michel D Sauve; Narmin Kassam; Holly Kamitakahara
Journal:  World J Gastroenterol       Date:  2010-05-21       Impact factor: 5.742

Review 3.  B vitamins, homocysteine, and bone disease: epidemiology and pathophysiology.

Authors:  Robert R McLean; Marian T Hannan
Journal:  Curr Osteoporos Rep       Date:  2007-09       Impact factor: 5.096

4.  Hip fracture risk in patients with a diagnosis of pernicious anemia.

Authors:  Nathan A Merriman; Mary E Putt; David C Metz; Yu-Xiao Yang
Journal:  Gastroenterology       Date:  2009-12-21       Impact factor: 22.682

Review 5.  The Unexplored Crossroads of the Female Athlete Triad and Iron Deficiency: A Narrative Review.

Authors:  Dylan L Petkus; Laura E Murray-Kolb; Mary Jane De Souza
Journal:  Sports Med       Date:  2017-09       Impact factor: 11.136

6.  Low bone mineral density and bone mineral content are associated with low cobalamin status in adolescents.

Authors:  Rosalie A M Dhonukshe-Rutten; Marijke van Dusseldorp; Jörn Schneede; Lisette C P G M de Groot; Wija A van Staveren
Journal:  Eur J Nutr       Date:  2004-08-30       Impact factor: 5.614

7.  Bone density and hemoglobin levels in older persons: results from the InCHIANTI study.

Authors:  Matteo Cesari; Marco Pahor; Fulvio Lauretani; Brenda W H J Penninx; Benedetta Bartali; Roberto Russo; Antonio Cherubini; Richard Woodman; Stefania Bandinelli; Jack M Guralnik; Luigi Ferrucci
Journal:  Osteoporos Int       Date:  2004-09-28       Impact factor: 4.507

8.  Chronic gastritis and bone mineral density in women.

Authors:  Adriana M Kakehasi; Carolinne B Rodrigues; Ariane V Carvalho; Alfredo J A Barbosa
Journal:  Dig Dis Sci       Date:  2008-08-07       Impact factor: 3.199

9.  Do patients with gastroesophageal reflux disease exhibit compromised bone quality prior to proton pump inhibitor therapy?

Authors:  Kristin M Aasarød; Mats P Mosti; Malin T Finstad; Astrid K Stunes; Reidar Fossmark; Unni Syversen
Journal:  Bone Rep       Date:  2021-05-20

10.  Atrophic gastritis: a related factor for osteoporosis in elderly women.

Authors:  Hye Won Kim; Yang-Hyun Kim; Kyungdo Han; Ga Eun Nam; Gwang Seon Kim; Byoung-Duck Han; Anna Lee; Ji Yong Ahn; Byung Joon Ko
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.